These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38872044)

  • 1. ASO Author Reflections: Survival Outcomes of Patients with Esophageal Cancer and Post-chemoradiotherapy Surgical T4b Disease: Is Palliative Resection Justified?
    Yang TY; Yeh CJ; Chiu CH; Chao YK
    Ann Surg Oncol; 2024 Oct; 31(10):6712-6713. PubMed ID: 38872044
    [No Abstract]   [Full Text] [Related]  

  • 2. Survival Outcomes of Patients with Esophageal Cancer and Post-chemoradiotherapy Surgical T4b Disease: Is Palliative Resection Justified?
    Yang TY; Yeh CJ; Chiu CH; Chao YK
    Ann Surg Oncol; 2024 Oct; 31(10):6628-6634. PubMed ID: 38780688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological factors predicting R0 resection and long-term survival after esophagectomy in patients with T4 esophageal cancer undergoing induction chemotherapy or chemoradiotherapy.
    Karimata H; Shimoji H; Nishimaki T
    Surg Today; 2015 Apr; 45(4):479-86. PubMed ID: 25059344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ASO Author Reflections: More May Not Be Better.
    Worrell SG; Linden PA
    Ann Surg Oncol; 2020 Feb; 27(2):509-510. PubMed ID: 31673943
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: Surgical Resection of Esophageal Neuroendocrine Tumors Should Be Considered as an Integral Part of Multimodal Therapy in Localized Disease.
    Erdem S; Worni M
    Ann Surg Oncol; 2020 Mar; 27(3):681-682. PubMed ID: 31741110
    [No Abstract]   [Full Text] [Related]  

  • 6. Salvage Esophagectomy After Definitive Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Who Really Benefits from this High-Risk Surgery?
    Watanabe M; Mine S; Nishida K; Yamada K; Shigaki H; Matsumoto A; Sano T
    Ann Surg Oncol; 2015 Dec; 22(13):4438-44. PubMed ID: 25862582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ASO Author Reflections: Fathoming the Dilemma of the Optimal Time to Surgery for Patients with Resectable Esophageal Cancer After Neoadjuvant Chemoradiotherapy.
    Li J; Wang Q
    Ann Surg Oncol; 2024 Jun; 31(6):3852-3853. PubMed ID: 38270832
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: Quality Improvement in Minimally Invasive Esophagectomy.
    Salo JC
    Ann Surg Oncol; 2019 Jan; 26(1):188-189. PubMed ID: 30478633
    [No Abstract]   [Full Text] [Related]  

  • 9. ASO Author Reflections: Does Thoracic Duct Resection Impact Long-Term Survival After Esophagectomy?
    Aiolfi A; Bona D; Markar SR; Bonavina L
    Ann Surg Oncol; 2024 Oct; 31(10):6710-6711. PubMed ID: 39020110
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: Prognostic Stratification and the Value of Adjuvant Therapy in Thoracic Esophageal Squamous Cell Carcinoma Patients After Esophagectomy.
    Deng W; Chen J; Xiao Z
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):802-803. PubMed ID: 31654164
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Implications of Conversion Surgery After Induction Therapy for T4b Thoracic Esophageal Squamous Cell Carcinoma.
    Miyata H; Sugimura K; Motoori M; Omori T; Yamamoto K; Yanagimoto Y; Shinno N; Yasui M; Takahashi H; Wada H; Ohue M; Yano M
    Ann Surg Oncol; 2019 Dec; 26(13):4737-4743. PubMed ID: 31414291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of neoadjuvant chemoradiotherapy on perioperative outcomes, tumor pathology, and survival in clinical stage II and III esophageal cancer.
    Markar SR; Bodnar A; Rosales J; Song G; Low DE
    Ann Surg Oncol; 2013 Nov; 20(12):3935-41. PubMed ID: 23892525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esophagectomy versus definitive chemoradiotherapy for patients with clinical stage N0 and pathological stage T1b esophageal squamous cell carcinoma after endoscopic submucosal dissection: study protocol for a multicenter randomized controlled trial (Ad-ESD Trial).
    Yang Y; Su Y; Zhang X; Liu J; Zhang H; Li B; Hua R; Tan L; Chen H; Li Z
    Trials; 2020 Jul; 21(1):603. PubMed ID: 32611448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pretreatment imaging on survival of esophagectomy after induction therapy for esophageal cancer: who should be given the benefit of the doubt?: esophagectomy outcomes of patients with suspicious metastatic lesions.
    Erhunmwunsee L; Englum BR; Onaitis MW; D'Amico TA; Berry MF
    Ann Surg Oncol; 2015 Mar; 22(3):1020-5. PubMed ID: 25234017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison Between Esophagectomy and Definitive Chemoradiotherapy in Patients With Esophageal Cancer.
    Wang BY; Hung WH; Wu SC; Chen HC; Huang CL; Lin CH; Chen HS
    Ann Thorac Surg; 2019 Apr; 107(4):1060-1067. PubMed ID: 30571951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Clinical T1N0M0 Esophageal Cancer.
    Yang AJ; Choi SH; Byun HK; Kim HJ; Choi J; Lee YC; Lee SK; Park KR; Lee CG
    Gut Liver; 2019 May; 13(3):315-324. PubMed ID: 30600672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of transthoracic esophagectomy with definitive chemoradiotherapy as initial treatment for patients with esophageal squamous cell carcinoma who could tolerate transthoracic esophagectomy.
    Matsuda S; Tsubosa Y; Niihara M; Sato H; Takebayashi K; Kawamorita K; Mori K; Tsushima T; Yokota T; Ogawa H; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Ann Surg Oncol; 2015; 22(6):1866-73. PubMed ID: 25564176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer: choice of new approach.
    Suzuki G; Yamazaki H; Aibe N; Masui K; Sasaki N; Shimizu D; Kimoto T; Shiozaki A; Dohi O; Fujiwara H; Ishikawa T; Konishi H; Naito Y; Otsuji E; Yamada K
    Radiat Oncol; 2018 Dec; 13(1):246. PubMed ID: 30547811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASO Author Reflections: Prediction of Morbidity and Mortality After Esophagectomy: A Systematic Review.
    van Nieuw Amerongen MP; de Grooth HJ; Veerman GL; Ziesemer KA; van Berge Henegouwen MI; Tuinman PR
    Ann Surg Oncol; 2024 May; 31(5):3471-3472. PubMed ID: 38451389
    [No Abstract]   [Full Text] [Related]  

  • 20. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
    Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
    BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.